We are live on ! Find out more
Balyasny Asset Management

Balyasny Asset Management Portfolio holdings

AUM $50.9B
1-Year Est. Return 42.98%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+42.98%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$50.9B
AUM Growth
-$2.48B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
2,755
New
Increased
Reduced
Closed

Top Buys

1 +$626M
2 +$447M
3 +$436M
4
RTX icon
RTX Corp
RTX
+$434M
5
STZ icon
Constellation Brands
STZ
+$320M

Top Sells

1 +$1.13B
2 +$502M
3 +$436M
4
EXAS
Exact Sciences
EXAS
+$415M
5
EA icon
Electronic Arts
EA
+$388M

Sector Composition

1 Technology 14.76%
2 Industrials 14.18%
3 Consumer Discretionary 12.91%
4 Healthcare 11.74%
5 Financials 11.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AUGO
2126
Aura Minerals Inc
AUGO
$4.7B
-33,650
NIQ
2127
NIQ Global Intelligence PLC
NIQ
$2.43B
-92,875
AROC icon
2128
Archrock
AROC
$6.22B
-980,165
ASHR icon
2129
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.83B
-29,197
DBRG icon
2130
DigitalBridge
DBRG
$2.9B
-3,670,404
DC icon
2131
Dakota Gold
DC
$635M
-103,348
DENN
2132
DELISTED
Denny's
DENN
-1,477,067
DGII icon
2133
Digi International
DGII
$2.51B
-10,717
DIBS icon
2134
1stdibs.com
DIBS
$143M
-10,983
DQ
2135
Daqo New Energy
DQ
$980M
-60,625
DSL
2136
DoubleLine Income Solutions Fund
DSL
$1.24B
-416,584
DT icon
2137
Dynatrace
DT
$12.1B
0
DUOL icon
2138
Duolingo
DUOL
$5.77B
-35,392
DVAX
2139
DELISTED
Dynavax Technologies
DVAX
-567,389
DYN icon
2140
Dyne Therapeutics
DYN
$3.06B
-432,986
E icon
2141
ENI
E
$79.5B
-15,050
EAT icon
2142
Brinker International
EAT
$6.56B
-1,142,263
ECPG icon
2143
Encore Capital Group
ECPG
$1.77B
-26,778
EDIV icon
2144
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.24B
0
EE icon
2145
Excelerate Energy
EE
$1.04B
-37,593
MC icon
2146
Moelis & Co
MC
$5.24B
-885,321
MCW
2147
DELISTED
Mister Car Wash
MCW
-280,494
OTTR icon
2148
Otter Tail
OTTR
$3.82B
-15,313
SION
2149
Sionna Therapeutics
SION
$1.55B
-1,406
AARD
2150
Aardvark Therapeutics
AARD
$78.5M
-13,817